LoginGet started
Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Swedish Orphan Biovitrum AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
C2020
December 31st
2021
December 31st
C2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSInterim ReportARSInterim ReportARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,3044,2173,2953,3212,954
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-5465033161,040
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,665-1,360-334-1,480-2,724
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,6344,9265,4704,5764,470
Capital Expenditures-9,746-3,852-370-1,477-4,943
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-11,939-1123—-16,961
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Sale of Intangible Assets
Cash from Investing Activities-21,685-3,964-367-1,477-21,904
Financing Cash Flow Items-1288-351-438-203
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities15,780-1,282-4,474-2,90217,012
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2,262-333641316-457